Advertisement
Original article| Volume 60, ISSUE 6, P578-584, September 15, 2006

Prefrontal Electrophysiologic “Noise” and Catechol-O-Methyltransferase Genotype in Schizophrenia

      Background

      Increased variability of stimulus-induced prefrontal electromagnetic activity (“noise”) has been associated with genetic risk for schizophrenia. On the basis of animal experiments and computational models, we have predicted that this prefrontal “noise” phenotype would be related to variation in prefrontal dopamine (DA) signaling, which itself might be abnormal in schizophrenia. In the present study, the effect of a functional single nucleotide polymorphism (val108/158met) within the catechol-O-methyltransferase (COMT) gene on prefrontal “noise” was examined, because the COMT enzyme is involved in cortical synaptic dopamine metabolism and weakly predictive of risk for schizophrenia.

      Methods

      A Caucasian sample comprising 112 unrelated normal subjects, 83 schizophrenic probands, and 87 of their unaffected siblings was investigated, all of whom had measures of prefrontal “noise” estimated from event-related electroencephalogram during an auditory oddball task.

      Results

      The val108/158met genotype was significantly associated with prefrontal “noise”; homozygous Val-carriers had greatest prefrontal “noise” values; odds ratio (OR) = 2.37 (95% confidence interval [CI] 1.37–4.10), p = 003. The genotype-phenotype association was stronger when only considering male subjects with an OR = 3.37 (95% CI: 1.63–6.98), p = 002.

      Conclusions

      The results suggest that COMT genotype impacts the level of prefrontal physiologic “noise.”

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abi-Dargham A.
        • Mawalawi O.
        • Lombardo I.
        • Gil R.
        • Martinez D.
        • Huang Y.
        • et al.
        Prefrontal dopamine D1 receptors and working memory in schizophrenia.
        J Neurosci. 2002; 22: 3708-3719
        • Akil M.
        • Kolachana B.S.
        • Rothmond D.A.
        • Hyde T.M.
        • Weinberger D.R.
        • Kleinman J.E.
        Catechol-O-methyltransferase genotype and dopamine regulation in the human brain.
        J Neurosci. 2003; 23: 2008-2013
        • Akil M.
        • Pierri J.N.
        • Whitehead R.E.
        • Edgar C.L.
        • Mohila C.
        • Sampson A.R.
        • Lewis D.A.
        Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.
        Am J Psychiatry. 1999; 156: 1580-1589
        • Baudena P.
        • Halgren E.
        • Heit G.
        • Clarke J.M.
        Intracerebral potentials to rare target and distractor auditory and visual stimuli. III. Frontal cortex.
        Electroencephalogr Clin Neurophysiol. 1995; 94: 251-264
        • Bearden C.E.
        • Jawad A.F.
        • Lynch D.R.
        • Sokol S.
        • Kanes S.J.
        • McDonald-McGinn D.M.
        • et al.
        Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome.
        Am J Psychiatry. 2004; 161: 1700-1702
        • Bertolino A.
        • Caforio G.
        • Blasi G.
        • De Candia M.
        • Latorre V.
        • Petruzzella V.
        • et al.
        Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
        Am J Psychiatry. 2004; 161: 1798-1805
        • Bilder R.M.
        • Volavka J.
        • Czobor P.
        • Malhotra A.K.
        • Kennedy J.L.
        • Ni X.
        • et al.
        Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
        Biol Psychiatry. 2002; 52: 701-707
        • Callicott J.H.
        • Bertolino A.
        • Mattay V.S.
        • Langheim F.J.
        • Duyn J.
        • Coppola R.
        • et al.
        Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.
        Cereb Cortex. 2000; 10: 1078-1092
        • Caspi A.
        • Reichenberg A.
        • Weiser M.
        • Rabinowitz J.
        • Kaplan Z.
        • Knobler H.
        • et al.
        Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode.
        Schizophr Res. 2003; 65: 87-94
        • Chen J.
        • Lipska B.K.
        • Halim N.
        • Ma Q.D.
        • Matsumoto M.
        • Melhem S.
        • et al.
        Functional analysis of genetic variation in COMT: Effects on mRNA, protein and enzyme activity in postmortem brain.
        Am J Hum Genet. 2004; 75: 807-821
        • Diamond A.
        • Briand L.
        • Fossella J.
        • Gehlbach L.
        Genetic and neurochemical modulation of prefrontal functions in children.
        Am J Psychiatry. 2004; 161: 125-132
        • Egan M.F.
        • Goldberg T.E.
        • Gscheidle T.
        • Weirich M.
        • Bigelow L.B.
        • Weinberger D.R.
        Relative risk of attention deficits in siblings of patients with schizophrenia.
        Am J Psychiatry. 2000; 157: 1309-1316
        • Egan M.F.
        • Goldberg T.E.
        • Kolachana B.S.
        • Callicott J.H.
        • Mazzanti C.M.
        • Straub R.E.
        • et al.
        Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia.
        Proc Natl Acad Sci U S A. 2001; 98: 6917-6922
        • Egan M.F.
        • Kojima M.
        • Callicott J.H.
        • Goldberg T.E.
        • Kolachana B.S.
        • Bertolino A.
        • et al.
        The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.
        Cell. 2003; 112: 257-269
        • Egan M.F.
        • Straub R.E.
        • Goldberg T.E.
        • Yakub I.
        • Calicott J.H.
        • Hariri A.R.
        • et al.
        Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.
        Proc Natl Acad Sci U S A. 2004; 101: 12604-12609
        • First M.B.
        • Spitzer R.L.
        • Gibbon M.
        • Williams J.B.W.
        Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-1). Biometrics Research, New York1996
        • Fleiss J.L.
        Statistical Methods for Rates and Proportions. 2nd ed. John Wiley & Sons, New York1981
        • Foltynie T.
        • Goldberg T.E.
        • Lewis S.G.
        • Blackwell A.D.
        • Kolachana B.S.
        • Weinberger D.R.
        • et al.
        Planning ability in Parkinson′s disease is influenced by the COMT val158met polymorphism.
        Mov Disorder. 2004; 19: 885-891
        • Gallinat J.
        • Bajbouj M.
        • Sander T.
        • Schlattmann P.
        • Ferro E.F.
        • Goldman D.
        • Winterer G.
        Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing.
        Biol Psychiatry. 2003; 54: 40-48
        • Gallinat J.
        • Mulert C.
        • Bajbouj M.
        • Rentzsch J.
        • Senkowski D.
        • Schunter J.
        • et al.
        Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia.
        Neuroimage. 2002; 17: 110-127
        • Glatt S.J.
        • Faraone S.V.
        • Tsuang M.T.
        Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies.
        Am J Psychiatry. 2003; 160: 469-476
        • Gogos J.A.
        • Morgan M.
        • Luine V.
        • Santha M.
        • Ogawa S.
        • Pfaff D.
        • Karayiorgou M.
        Catechol-O-methyltransferase-deficient mice exhibit sexually dimorhic changes in catecholamine levels and behavior.
        Proc Natl Acad Sci U S A. 1998; 95: 9991-9996
        • Goldberg T.E.
        • Egan M.F.
        • Gscheidle T.
        • Coppola R.
        • Weickert T.
        • Kolachana B.S.
        • et al.
        Executive subprocesses in working memory: Relationship to COMT Val158Met genotype in schizophrenia.
        Arch Gen Psychiatry. 2003; 60: 889-896
        • Halgren E.
        • Baudena P.
        • Clarke J.M.
        • Heit G.
        • Liegeois C.
        • Chauvel P.
        • Musolino A.
        Intracerebral potentials to rare target and distractor auditory and visual stimuli. I. Superior temporal plane and parietal lobe.
        Electroenceph Clin Neurophysiol. 1995; 94: 191-220
        • Halgren E.
        • Baudena P.
        • Clarke J.M.
        • Heit G.
        • Marinkovic K.
        • Devaux B.
        • et al.
        Intracerebral potentials to rare target and distractor auditory and visual stimuli. II. Medial, lateral and posterior temporal lobe.
        Electroenceph Clin Neurophysiol. 1995; 94: 229-250
        • Harrison P.J.
        • Weinberger D.R.
        Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence.
        Mol Psychiatry. 2005; 10: 40-68
        • Hartwell J.
        EEGSYS Version 5.7 Users’ Guide. Friends Medical Science Research Center, Inc, Baltimore1998
        • Huotari M.
        • Gogos J.A.
        • Karayiorgou M.
        • Koponen O.
        • Forsberg M.
        • Raasmaja A.
        • et al.
        Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice.
        Eur J Neurosci. 2002; 15: 246-256
        • Hyoki K.
        • Shigeta M.
        • Tsuno N.
        • Kawamuro Y.
        • Kinoshita T.
        Quantitative electro-oculography and electroencephalography of alertness.
        Electroenceph Clin Neurophysiol. 1998; 106: 213-219
        • Jastak S.
        • Wilkinson G.S.
        Wide Range Achievement Test. Jastak Associates, Wilmington, Delaware1984
        • Karoum F.
        • Chrapusta S.J.
        • Egan M.F.
        3-methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
        J Neurochem. 1994; 63: 972-979
        • Lachman H.M.
        • Papolos D.F.
        • Saito T.
        • Yu Y.M.
        • Szumlanski C.L.
        • Weinshilboum R.M.
        Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders.
        Pharmacogenetics. 1996; 6: 243-250
        • Li Y.-H.
        • Wirth T.
        • Huotari M.
        • Laitinen K.
        • MacDonald E.
        • Mannisto P.T.
        No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: A microdialysis study in anaesthetized rats.
        Eur J Pharm. 1998; 356: 127-137
        • Lotta T.
        • Vidgren J.
        • Tilgmann C.
        • Ulmanen I.
        • Melen K.
        • Julkunen I.
        • Taskinen J.
        Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme.
        Biochemistry. 1995; 34: 4202-4210
        • Malhotra A.K.
        • Kestler L.J.
        • Mazzanti C.
        • Bates J.A.
        • Goldberg T.
        • Goldman D.
        A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition.
        Am J Psychiatry. 2002; 159: 652-654
        • Matsumoto M.
        • Weickert C.S.
        • Akil M.
        • Lipska B.K.
        • Hyde T.M.
        • Herman M.M.
        • et al.
        Catechol-O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function.
        Neuroscience. 2003; 116: 127-137
        • Mattay V.S.
        • Goldberg T.E.
        • Fera F.
        • Hariri A.R.
        • Tessitore A.
        • Egan M.F.
        • et al.
        Catechol-O-methyltransferase val158met genotype and individual variation in the brain response to amphetamine.
        Proc Natl Acad Sci U S A. 2003; 100: 6186-6191
        • Möcks J.
        • Gasser T.
        • Köhler W.
        Basic statistical parameters of event-related potentials.
        J Psychophysiol. 1988; 2: 61-70
        • Mulert C.
        • Gallinat J.
        • Schlattmann P.
        • Dorn H.
        • Pascual-Marqui R.
        • Mientus S.
        • et al.
        Reduced event-related current density in the anterior cingulate cortex in schizophrenia.
        Neuroimage. 2001; 13: 589-600
        • Murphy K.C.
        • Jones L.A.
        • Owen M.J.
        High rates of schizophrenia in adults with velo-cardio-facial syndrome.
        Arch Gen Psychiatry. 1999; 56: 940-945
        • Pulver A.E.
        • Karayiorgou M.
        • Wolyniec P.S.
        • Lasseter V.K.
        • Kasch L.
        • Nestadt G.
        • et al.
        Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on chromosome 22q12-q13.1: Part 1.
        Am J Med Genet. 1994; 54: 36-43
        • Rosa A.
        • Peralta V.
        • Cuesta M.J.
        • Zarzuela A.
        • Serrano F.
        • Martinez-Larrea A.
        • Fananas L.
        New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis.
        Am J Psychiatry. 2004; 161: 1110-1112
        • Sazci A.
        • Ergul E.
        • Kucukali I.
        • Kilic G.
        • Kaya G.
        • Kara I.
        Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
        Brain Res Mol Brain Res. 2004; 132: 51-56
        • Shifman S.
        • Bronstein M.
        • Sternfeld M.
        • Pisanté-Shalom A.
        • Lev-Lehman E.
        • Weizman A.
        • et al.
        A highly significant association between COMT haplotype and schizophrenia.
        Am J Hum Genet. 2002; 71: 1296-1302
        • Statsoft
        Statistica for Windows. StatSoft, Tulsa1998
        • Tunbridge E.M.
        • Bannerman D.M.
        • Sharp T.
        • Harrison P.J.
        Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex.
        J Neurosci. 2004; 24: 5331-5335
        • Weickert T.W.
        • Goldberg T.E.
        • Mishara A.
        • Apud J.A.
        • Kolachana B.S.
        • Egan M.F.
        • Weinberger D.R.
        Catechol-O-methyltransferase val158met genotype predicts working memory response to antipsychotic medications.
        Biol Psychiatry. 2004; 56: 677-682
        • Weinberger D.R.
        • Berman K.F.
        • Illowsky B.P.
        Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.
        Arch Gen Psychiatry. 1988; 45: 609-615
        • Weinberger D.R.
        • Egan M.F.
        • Bertolino A.
        • Callicott J.H.
        • Mattay V.S.
        • Lipska B.K.
        • et al.
        Prefrontal neurons and the genetics of schizophrenia.
        Biol Psychiatry. 2001; 50: 825-844
        • Weinshilboum R.M.
        • Otterness D.M.
        • Szumlanski C.L.
        Methylation pharmacogenetics: Catechol-O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase.
        Annu Rev Pharmacol Toxicol. 1999; 39: 19-52
        • Winterer G.
        • Adams C.M.
        • Jones D.W.
        • Knutson B.
        Volition to action—an event-related fMRI-study.
        Neuroimage. 2002; 17: 851-857
        • Winterer G.
        • Coppola R.
        • Egan M.F.
        • Goldberg T.E.
        • Weinberger D.R.
        Functional and effective frontotemporal connectivity and genetic risk for schizophrenia.
        Biol Psychiatry. 2003; 54: 1181-1192
        • Winterer G.
        • Coppola R.
        • Goldberg T.E.
        • Egan M.F.
        • Jones D.W.
        • Weinberger D.R.
        Prefrontal broadband noise, working memory and genetic risk for schizophrenia.
        Am J Psychiatry. 2004; 161: 490-500
        • Winterer G.
        • Egan M.F.
        • Coppola R.
        • Jones D.W.
        • Sanchez C.E.
        • Weinberger D.R.
        P300 and genetic risk for schizophrenia.
        Arch Gen Psychiatry. 2003; 60: 1158-1167
        • Winterer G.
        • Egan M.F.
        • Raedler T.
        • Coppola R.
        • Weinberger D.R.
        Event-related potentials and genetic risk for schizophrenia.
        Biol Psychiatry. 2001; 50: 407-417
        • Winterer G.
        • Egan M.F.
        • Raedler T.
        • Hyde T.
        • Coppola R.
        • Weinberger D.R.
        An association between reduced interhemispheric coherence in the temporal lobe and genetic risk for schizophrenia.
        Schizophr Res. 2001; 49: 129-143
        • Winterer G.
        • Goldman D.
        Genetics of human prefrontal function.
        Brain Res Brain Res Rev. 2003; 43: 134-163
        • Winterer G.
        • Mulert C.
        • Pascual-Marqui R.
        • Dorn H.
        • Frick K.
        • Herrmann W.M.
        P300 and LORETA: A comparison between normal subjects and schizophrenic patients.
        Brain Topography. 2001; 13: 299-313
        • Winterer G.
        • Weinberger D.R.
        Cortical signal-to-noise ratio: Insight into the pathophysiology and genetics of schizophrenia.
        Clin Neurosci Res. 2003; 3: 55-66
        • Winterer G.
        • Weinberger D.R.
        Genes, dopamine and cortical signal-to-noise ratio in schizophrenia.
        Trends Neurosci. 2004; 27: 683-690
        • Winterer G.
        • Ziller M.
        • Dorn H.
        • Frick K.
        • Mulert C.
        • Dahhan N.
        • et al.
        Cortical activation, signal-to-noise ratio and stochastic resonance during information processing in man.
        Clin Neurophysiol. 1999; 110: 1193-1203
        • Winterer G.
        • Ziller M.
        • Dorn H.
        • Frick K.
        • Mulert C.
        • Wuebben Y.
        • et al.
        Schizophrenia: Reduced signal-to-noise ratio and impaired phase-locking during information processing.
        Clin Neurophysiol. 2000; 111: 837-849